Savara Inc. reported $257K of revenue over the trailing twelve months. 7 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $257K (to Q4 2020). Net income: −$139M, trailing twelve months to Q2 2026. Free cash flow: −$111M, trailing twelve months to Q2 2026. EPS: −$0.58, trailing twelve months to Q2 2026.

SVRASavara Inc.

Healthcare

$4.93+40% 1Y

$4.93

$3.3752 weeks$6.94

SVRA as reported

Savara Inc. reported $257K of revenue over the trailing twelve months. 7 reported series are charted on this page, each one as filed.

$257K

Revenue, trailing twelve months · to Q4 2020 · every figure below is as filed, with no scoring applied

Net income: −$139M
Net income · +26% year on year · trailing twelve months to Q2 2026
Free cash flow: −$111M
Free cash flow · +11% year on year · trailing twelve months to Q2 2026
EPS: −$0.58
EPS · +16% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SVRA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$257K	n/a	Q4 2020 · 22 quarters behind
Net income	−$139M	+26%	Q2 2026
EPS	−$0.58	+16%	Q2 2026
ROE	−88%	n/a	Q2 2026
ROA	−65%	n/a	Q2 2026
ROIC	7202%	n/a	Q2 2026
Free cash flow	−$111M	+11%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.